(Q46214180)

20 December 2017

title

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa (English)

1 reference

20 December 2017

travel-associated infection

main subject

0 references

Schistosoma haematobium

0 references

1 reference

Iran Mendonça da Silva

1

1 reference

20 December 2017

Roberto Thiengo

2

1 reference

20 December 2017

Maria José Conceição

3

1 reference

20 December 2017

Luis Rey

4

1 reference

20 December 2017

Henrique Leonel Lenzi

5

1 reference

20 December 2017

Edson Pereira Filho

6

1 reference

20 December 2017

Paulo César Ribeiro

7

1 reference

20 December 2017

publication date

1 July 2005

1 reference

20 December 2017

Memórias do Instituto Oswaldo Cruz

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 December 2017

volume

100

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

445-449

1 reference

20 December 2017

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Drugs five years later: praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Detection of praziquantel resistance in schistosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Long-term efficacy of single-dose oral treatment in schistosomiasis haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

The potential of artemether for the control of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Resolution and resurgence of schistosoma haematobium-induced pathology after community-based chemotherapy in ghana, as detected by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

10.1590/S0074-02762005000400018

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

16113896

1 reference

20 December 2017